Trials / Sponsors / EyebioKorea, Inc.
EyebioKorea, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degenerat Neovascular Age-related Macular Degeneration (nAMD) | Phase 2 | 2024-08-01 |
| Completed | Safety, Tolerability and Pharmacokinetics of EB-203 Eye Drops in Healthy Volunteers Healthy | Phase 1 | 2022-06-29 |